Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Processa Pharmaceuticals Inc (NASDAQ: PCSA)

 
PCSA Technical Analysis
5
As on 9th Jun 2023 PCSA STOCK Price closed @ 0.71 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.09 & Strong Sell for SHORT-TERM with Stoploss of 4.19 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

PCSASTOCK Price

Open 0.77 Change Price %
High 0.77 1 Day -0.01 -1.39
Low 0.64 1 Week 0.16 29.09
Close 0.71 1 Month 0.17 31.48
Volume 26942 1 Year -4.24 -85.66
52 Week High 5.21 | 52 Week Low 0.41
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
PCSA
Daily Charts		 PCSA
Intraday Charts		 Whats New @
Bazaartrend		 PCSA
Free Analysis
 
PCSA Important Levels Intraday
RESISTANCE0.96
RESISTANCE0.88
RESISTANCE0.83
RESISTANCE0.78
SUPPORT0.64
SUPPORT0.59
SUPPORT0.54
SUPPORT0.46
 
PCSA Forecast May 2024
Share
4th UP Forecast4.83
3rd UP Forecast3.51
2nd UP Forecast2.69
1st UP Forecast1.88
1st DOWN Forecast-0.46
2nd DOWN Forecast-1.27
3rd DOWN Forecast-2.09
4th DOWN Forecast-3.41
 
PCSA Weekly Forecast
4th UP Forecast1.69
3rd UP Forecast1.38
2nd UP Forecast1.18
1st UP Forecast0.99
1st DOWN Forecast0.43
2nd DOWN Forecast0.24
3rd DOWN Forecast0.04
4th DOWN Forecast-0.27
 
PCSA Forecast2024
4th UP Forecast10.5
3rd UP Forecast7.36
2nd UP Forecast5.42
1st UP Forecast3.48
1st DOWN Forecast-2.06
2nd DOWN Forecast-4
3rd DOWN Forecast-5.94
4th DOWN Forecast-9.08
 
 
PCSA Other Details
Segment EQ
Market Capital 107047560.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
PCSA Address
PCSA
 
PCSA Latest News
 
Your Comments and Response on Processa Pharmaceuticals Inc
 
PCSA Business Profile
Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase II clinical trials for the treatment of necrobiosis lipoidica, a chronic disfiguring condition. The company is also developing PCS12852, a novel selective 5-hydroxytryptamine 4 (5-HT4) receptor agonist that is in Phase II clinical trials for the treatment of gastroparesis; and PCS6422, an oral, potent, selective, and irreversible inhibitor that is in Phase I clinical trials for treating metastatic colorectal and breast cancer. It has a license agreement with Akashi Therapeutics, Inc. to develop and commercialize PCS100, an anti-fibrotic and anti-inflammatory drug. The company was incorporated in 2011 and is based in Hanover, Maryland. Address: 7380 Coca Cola Drive, Hanover, MD, United States, 21076
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service